Nephros (NASDAQ:NEPH) Trading Down 0.3% – What’s Next?

Shares of Nephros Inc. (NASDAQ:NEPH) were down 0.3% on Tuesday . The stock traded as low as $3.51 and last traded at $3.57. 3,966 shares were traded during mid-day trading, a decline of 67% from the average session volume of 12,140 shares. The stock had previously closed at $3.58.

Analyst Ratings Changes

Separately, Weiss Ratings raised Nephros from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, June 18th. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $6.00.

Nephros Stock Up 0.9%

The company has a market cap of $36.92 million, a P/E ratio of 48.58 and a beta of 1.49. The business has a fifty day moving average of $3.35 and a 200 day moving average of $3.76.

Nephros (NASDAQ:NEPH) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.01 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.01. Nephros had a net margin of 4.06% and a return on equity of 7.66%. The company had revenue of $5.21 million during the quarter, compared to analyst estimates of $5.02 million.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of NEPH. Dimensional Fund Advisors LP lifted its position in Nephros by 52.5% during the first quarter. Dimensional Fund Advisors LP now owns 20,745 shares of the company’s stock valued at $62,000 after purchasing an additional 7,144 shares during the period. XTX Topco Ltd lifted its holdings in Nephros by 48.5% during the fourth quarter. XTX Topco Ltd now owns 21,617 shares of the company’s stock valued at $105,000 after purchasing an additional 7,062 shares in the last quarter. Quadrature Capital Ltd bought a new position in Nephros in the 4th quarter worth $112,000. Kestra Advisory Services LLC purchased a new stake in Nephros during the 4th quarter valued at approximately $29,000. Finally, Marshall Wace LLP bought a new position in shares of Nephros during the fourth quarter worth $107,000. 41.10% of the stock is owned by institutional investors.

About Nephros

Nephros, Inc is a development-stage company specializing in advanced water filtration and purification technologies for medical, laboratory, industrial and defense applications. The company’s core offering centers on proprietary hollow fiber ultrafilters designed to remove bacteria, viruses, endotoxins and particulates from water streams. These ultrafilters are used in hemodialysis systems to protect patient treatment, in pharmaceutical and laboratory environments to ensure water quality and in critical field-deployable units for military and emergency response.

The company’s product portfolio includes standalone filtration cartridges for point-of-use and point-of-entry installations in dialysis clinics and hospitals, as well as bench-top and portable water purification systems.